Colchicin (1) – Colxi®
For the prevention of ischaemic cardiovascular events in patients with atherosclerotic coronary heart disease following a myocardial infarction
Characteristics
| Start date | 01.03.2026 |
|---|---|
| Resolution | 20.08.2026 – active procedure |
| INN | Colchicin |
| Brand name | Colxi® |
| Pharm. company | Apontis Pharma Deutschland GmbH & Co. KG |
| G-BA Procedure ID | D-1302 |
| Therapeutic area | Cardiovascular diseases |
| Reason for procedure | Initial assessment |
Associated procedures
<< List of all resolutions